key: cord-0786074-5xxotzuz
authors: Yanagihara, Ted K.; Holland, Roger E.; Chera, Bhisham
title: Practical Challenges of Mask-to-Mask Encounters with Patients with Head and Neck Cancers Amid the COVID-19 Pandemic
date: 2020-05-27
journal: Adv Radiat Oncol
DOI: 10.1016/j.adro.2020.05.010
sha: 4a096c3258650f83cecdff5d20f7a10f94636a84
doc_id: 786074
cord_uid: 5xxotzuz

The coronavirus disease 2019 (COVID-19) pandemic has forced a re-design of care in radiation oncology. Perhaps more than any other disease site we commonly see, the evaluation and treatment of head and neck cancer has posed the greatest risk of COVID-19 transmission between patients and radiotherapy providers. In our early experience with the novel coronavirus, several staff members were exposed to a COVID-positive patient and this caused us to devise policies and procedures to mitigate further risk in a way that could practically be employed across a large health system while not compromising care delivery. Here, we formulate a concise summary of simple steps, including a novel thermoplastic mask fitting technique and procedures for intraoral immobilization devices, to guide practices and provide new layers of protection for both patients and staff.

The SARS-COVID-2 (aka COVID-19) pandemic is straining health care systems and 2 placing a disproportionate risk of morbidity and mortality on patients with active cancer. 1 The 3 safety of healthcare workers is of paramount importance during this time both to preserve their 4 well-being and ensure uninterrupted delivery of vital services to patients. Of the myriad of 5 challenges unique to radiation oncology practices at this time, the management of patients with 6 head and neck cancer (HNC) patients requires special attention. The care of patients with HNC 7

involves an in-depth examination of the upper aerodigestive tract (where aerosolization of 8 COVID-19 is possible), immobilization devices that require hands-on manipulation of the head 9

and neck (sometimes with intraoral treatment deices) on a daily basis, and a long treatment 10 course during which an initially COVID-negative patient may become exposed and even infected 11 with COVID-19. These factors and more must be considered in a patient population where 12 cough, shortness of breath, sore throat, and fatigue are common symptoms, where radiation is 13 typically given with immunosuppressive systemic agents, and where treatment typically may not 14 be delayed while waiting for pandemic-related constraints to subside. 2 15

It has been very challenging to re-design care (almost overnight) for our patients with 16

HNC. Though we have done our best to be proactive, we have been unable to predict and 17 prepare for all the potential failure modes of our standard workflows. Most healthcare systems 18 have implemented surgical mask polices for patients and healthcare workers: i.e. that surgical 19 masks are to be worn at all times by both parties when in the hospital. Incorporation of the 20 surgical mask policy into our standard workflows and interactions with patients with HNC has 21 been difficult. In our early experience with the pandemic, a small group of staff were exposed to aquaplast mask be made at simulation. Prior to this event, we allowed the surgical mask to be 24 removed during an in-office physical examination, simulation, and treatment. This patient tested 25 positive for COVID-19 within 24 hours of the simulation, resulting in the quarantine of several 26 of our radiation oncology staff. The quarantine recommendation was primarily made on the fact 27 that the patient's surgical mask was removed during simulation, and despite our staff wearing a 28 surgical mask at the time of simulation. 29

This experience prompted us to modify our risk-reduction policies in a way that could be 30 immediately deployed across a large health system that delivers radiation therapy at sites across 31 the state, which range from a large academic center to small and medium regional hospitals. The 32 guiding principal of these new policies is that all face-to-face encounters between providers and 33 patients are performed with both parties wearing masks ("mask-to-mask" encounters). The 

Physical examination is a key diagnostic study in the management of patients with HNC. 41

We administer a questionnaire screening for fever, or new/worsening symptoms of cough, sore 42 throat, shortness of breath, loss of taste or smell, or vomiting/diarrhea in anyone entering the 43 facility. Patients with a positive screen may require formal testing for COVID-19, but those with 44 a negative screen, further evaluation, including physical examination, is conducted with physical 45 distancing. However, physical distancing is not possible when conducting a proper head and neck examination, and the transoral examination and in-office nasopharyngolaryngoscopy place the examiner and others in the room at substantial risk of exposure/infection. If a patient coughs 48 or sneezes during the examination, COVID-19 can become aerosolized. Nasal decongestion and 49 anesthetization prior to fiberoptic examination is also an aerosolization procedure. The 50

American Academy Otolaryngology has recommended that all upper airway procedures should 51 be done with personal protective equipment (PPE, N95 mask, gown, eye shield, gloves). 3 We 52

have avoided the use of fiberoptic nasopharyngolaryngoscopy in most cases (except where it is 53 essential for management) because this is an aerosol-generating procedure that requires the use 54 of valuable fitted respirator masks and other personal protective gear. 4 and while a video visit may permit an assessment of oral candidiasis, a patient's dental health, or 89 tumor response, it cannot replace the mask-to-mask interaction. 90

In our early experience, we have found several additional benefits on utilizing telehealth 91 for in-office visits. First, this practice may allow medical students to continue participating in patient care at a time when there are several COVID-related educational restrictions. Second, 93 many patients appreciate the additional effort being placed on minimizing their direct contact 94 with healthcare workers and are satisfied knowing a provider can enter the room for a mask-to-95 mask interaction at the patient's discretion. Third, most telehealth platforms allow additional 96 providers to seamlessly join the interaction, which has lowered some barriers to multidisciplinary 97 encounters (e.g. a joint discussion with the patient's medical oncologist). And finally, on-98 treatment visits are well-suited for telehealth because an audio-visual connection can be 99 maintained throughout the clinic day in one or more examination rooms, through which multiple 100 providers can interact with the patient semi-remotely. 101

In accord with the Mask-to-Mask policy described for patient office visits, we devised 105 our CT simulation procedures such that no staff member is in the room with an unmasked 106 patient. Patients and providers enter the CT simulation suite with both parties wearing a personal 107 protective mask. The patient is prepared for immobilization with a thermoplastic mask (TM) and 108 any special immobilization devices (addressed in more detail below) are created. The heated TM 109 is placed over the patient's head and neck while a provider holds a single point on the TM in the 110 region of the patient's mouth. Holding this point at approximately six inches above the patient 111 while mask is lowered will create a circular retraction in the TM as it hardens, which allows the 112 patient to be comfortably immobilized without their personal protective mask becoming wet as it 113 tightens around their nose and mouth (Figure 2 ). For patient's wearing an ear-loop surgical mask, 114 placing tape over the strings reduces sticking between the TM and the personal protective mask.

Following CT simulation, the retracted portion of the TM can be cut away (a small modification 116 that is not expected to affect immobilization). When the simulation is complete and the TM is 117 being removed, either a provider or the patient can hold the personal protective mask in place 118 such that it not removed along with the TM. An alternative method used by some of our other 119 centers is to use an open-faced TM and place a non-stick barrier between the TM and surgical 120 mask during the TM making process. 121 122

The Mask-to-Mask policy during CT simulation applies similarly for daily radiation 125 treatments of HNC patients. Meaning, every effort is made to maintain the patient and providers' 126 personal protective masks are in place when sharing the same airspace. The treatment of HNC 127 patients often requires the use of customized dental guards, bite blocks, or tongue depressors 128 where a patient's protective mask must be removed for insertion and this challenges the Mask-to-129 Mask policy. However, patients may be reliably trained to insert their own intraoral device and 130 replace their protective mask while RTTs are outside the treatment area, which maintains the 131 Mask-to-Mask policy and minimizes patient-provider interaction during a potentially aerosol-132 generating procedure (Figure 3) . Still, if the creation or daily use of intraoral immobilization 133 devices requires a hands-on interaction with a provider, we recommend use of full personal 134 protective equipment for that provider, including fitted respirator mask, gown, eye protection, 135 and gloves that are disposed of after each use.

The effect of the COVID-19 pandemic on radiation oncology practices is without 139 precedent and it is difficult to predict what the near-and long-term will mean for cancer care. 140

Patients with HNC pose unique challenges even among cancer patients in the COVID-19 era due 141 to the prolonged treatment duration, inability to delay radiation for an extended period of time, 142 and the heightened risks posed to healthcare workers. Many unanswered questions remain, such 143 as how long to wait between a patient removing their mask and staff entering the room, how best 144 to sterilize a telehealth console being used by a patient, what is the optimal way to clean and 145 store intraoral devices, when to test or re-test patients prior to or during treatment, and how an 146 increased availability of rapid testing for COVID-19 infection and immunity might augment 147 these policies. The Mask-to-Mask policy and several simple procedural modifications represent 148 early steps to reduce the risk of viral transmission and as more is learned regarding COVID-19, 149 additional guidance can be given to inform best practices. 150

A woman with SCC of the left tonsil treated with chemoradiation over 10-years prior presented with a new primary HPV-positive SCC of the right tonsil with soft palate invasion. The left image was taken in the office during a face-to-face encounter prior to the arrival of the COVID-19 pandemic in our state. The patient began induction chemotherapy and after two cycles had an excellent treatment response. During this time, the mask-to-mask policy was developed and the patient returned for a combined in-person and video-based visit where the image on the right was obtained with the patient in an isolated exam room.

CT simulation where a TM is fitted to a patient wearing a personal protective mask. A point of the TM in the region of the nose and mouth is held prior to the TM being lowered onto the patient's face. By retracting the TM while it hardens, the patient's protective mask stays dry and comfortable around the nose and mouth. The region extending anteriorly can then be cut away after simulation. Abbreviation: TM = Thermoplastic mask.

A tongue depressor with a custom thermoplastic-bead mouthpiece ("popsicle stick") was created for a patient with HNSCC of the soft palate. The patient's personal mask required removal during CT simulation, but the distal end of the tongue depressor was removed such that all future uses could be done according to the Mask-On policy. The patient was trained to insert the device and then replace the personal protective mask prior to RTTs entering the room and immobilizing the patient with the TM. The mouthpiece may then be removed by the patient following treatment, cleaned, wrapped in cellophane and stored in a sealed biohazard bag until the next fraction's use. Abbreviations: HNSCC = Head and neck squamous cell carcinoma; RTT = Radiation therapist; TM = Thermoplastic mask.

Cancer patients in SARS-CoV-2 infection: a nationwide 154 analysis in China. The Lancet Oncology

Practice recommendations for risk-adapted 157 head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO 158 consensus statement

Otolaryngologists and the 161 COVID-19 Pandemic

Surviving Sepsis Campaign: guidelines on the 164 management of critically ill adults with Coronavirus Disease

Association of NCCN-Recommended Posttreatment Surveillance With Outcomes in Patients 168

Associated Oropharyngeal Squamous Cell Carcinoma